Omada Health

We’ve supported over 150k GLP-1 member journeys and learned that pairing treatment with clinically validated support drives outcomes. That’s why we’ve expanded our platform with GLP-1 prescribing. Learn more. omadahealth.com/resource-cente…

GLP‑1s shouldn’t just change the scale—they should change what you lose. Omada GLP‑1 members lost more fat, preserved muscle mass, and felt better overall. Learn more: buff.ly/HbKqzkA

We’re adding GLP‑1 prescribing to our proven behavior change platform—helping members benefit from the strong start these medications provide alongside a dedicated ecosystem of care, right from the start. Learn more. omadahealth.com/resource-cente…

As GLP-1s dramatically change obesity treatment, who is helping to ensure they’re a good investment for employers? Omada is, with our new GLP-1 prescribing capability. youtu.be/jCdKJZKFRFw

Not all GLP‑1 weight loss is equal. In 12 weeks, Omada GLP‑1 members lost, on average. 1.8x more weight and 2.1x more body fat, with better mental health and physical function. Learn more: buff.ly/BfXOx2b

Scaling nutrition support takes more than coaching alone. Omada partnered with @AWSAI & @AIatMeta to build OmadaSpark, an AI-powered nutrition tool built by fine-tuned Llama models on Amazon SageMaker AI. Learn more: tinyurl.com/b42b8hx8

Behavior change doesn’t happen in a single visit—or in a straight line. Adaptive care means adjusting goals as life changes, using technology to make food choices easier, and turning data into actionable insights. Learn more: tinyurl.com/bj4umc8f

We’ve expanded Omada’s cardiometabolic platform with Omada for Cholesterol, so one platform can support obesity, diabetes, hypertension, cholesterol, and GLP‑1 use— addressing how cardiovascular risk accumulates across multiple comorbidities. Learn more: omadahealth.com/research-and-i…

Omada is virtual care for real life. And now, that care includes cholesterol management. Omada for Cholesterol builds on 14 years of innovation and research. Learn about what fuels us: buff.ly/31nWb37

More than 86 million Americans are living with high cholesterol. Through whole-person care, we’re here to help change that. Together. Learn more about our innovation process: buff.ly/31nWb37

How can muscle loss of lean mass undermine long-term GLP-1 weight loss outcomes? Our latest whitepaper breaks it all down. Read it now. buff.ly/KbBmwNv

We believe the best health care delivery model is a holistic one where all facets of a member’s life are incorporated into the care plan. That’s what’s behind Omada for Cholesterol. Learn more about what’s behind our new program’s innovation: buff.ly/19tcd4F

We spoke with @FierceHealth about why cholesterol care can’t be an afterthought in cardiometabolic care. Omada for Cholesterol brings between‑visit support and human‑led, AI‑amplified care onto the same platform as obesity, hypertension, and diabetes. buff.ly/Fkxj4Ry

2/2 New data from Omada Insights Lab found that members who stopped taking their GLP-1s earlier than planned still experienced notable weight loss of 13.1% over 12 months, outperforming typical real-world outcomes of 6.8%. Learn more: buff.ly/2XCUJ92

1/2 ✨ Everyone loves a plot twist, even research scientists!

The best health care delivery model is a holistic one where all facets of a member’s life are incorporated into the care plan. That’s what’s behind Omada for Cholesterol. Learn more about what’s behind our new program’s innovation: youtu.be/0H8ngR6dSD8

More than 86 million Americans are living with high cholesterol. Through whole-person care, we’re here to help change that. Together. Learn more about our innovation process: omadahealth.com/research-and-i…

Employers are under pressure to offer GLP-1s but need options that won’t blow up budgets. Omada’s GLP-1 Flex Care adds a pathway to support obesity care while keeping medication spend outside the plan. Read more: tinyurl.com/3sbejhcy

2/2 For context, those who discontinued before one year lost an average of 13.1%. Read Omada Insights Lab’s latest research findings here: buff.ly/2XCUJ92

🏆 1/2 NEW GLP-1 weight loss data: Omada members who stayed their prescribed GLP-1 course for 12 months saw an average of 18.4% weight loss.